Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The participant must be a young person between the ages of 10 and 17 years old
- The participant must have a diagnosis of mild-to-moderate intellectual disability and/or a developmental disability, which may include autism
- The participant must have a diagnosis of moderate-to-severe asthma
- The participant's parent or legal guardian must be willing to answer questions about their child
- Both the parent or legal guardian and the young person must be able to understand what the study involves and follow the study rules for its entire duration
- The participant and/or their family must speak English or Spanish
- The participant must not currently be involved in any other studies that use digital inhalers
- Both male and female participants are welcome, and no specific birth control requirements apply
- The participant must currently use one of the following inhalers: Ventolin HFA, ProAir HFA, Advair HFA, Flovent HFA, Xopenex HFA, Symbicort HFA, Atrovent HFA, Proventil HFA, Alvesco HFA, Dulera HFA, or Asmanex HFA
Who may not be able to join:
- Participants who have a serious health condition or limited life expectancy that would make it difficult to properly take part in, be treated during, or be followed up on throughout the trial
- Participants whose parent, legal guardian, or representative is unwilling or unable to give written consent to join the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Larry Yin, MD, MSPH, Children's Hospital Los Angeles
Phone: 323-669-2534
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of smart inhaler device; Acceptability of smart inhaler; Usability of smart inhaler
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.